RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer

This study has been terminated.
(Manufacturer discontinued drug development.)
Information provided by (Responsible Party):
National Cancer Institute (NCI) Identifier:
First received: June 22, 2010
Last updated: May 22, 2015
Last verified: May 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2013
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)